Adam Wufsus

Adam Wufsus

Company: Novo Nordisk

Job title: Medical Director Rare Blood Disorders

Seminars:

Joint Q&A 5:00 pm

Read more

day: Day Two

Knowing What You Don’t Know: Utilizing Medical Affairs to Facilitate Patient-Centric Drug Development 4:30 pm

Developing medical affairs teams to enter into new therapeutic areas Benefits of patient engagement early in the development process Bringing an epigenetic therapy into a gene therapy treatment landscapeRead more

day: Day Two

PANEL: Clinical, Approval & Commercialization Challenges in a World with Non-Gtx Competitors 3:00 pm

Demonstrating value to practitioners and physicians to recruit relevant patients for your clinical trials What does the approval process look like in a field with active approved competitor therapies Building an effective commercialisation strategy for your gene therapy where current alternative therapies already exist What can we learn from alternative approvals within the blood disorders…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.